ADVERUM BIOTECHNOLOGIES, INC.

Profile

Company Names

ADVERUM BIOTECHNOLOGIES, INC.
AVALANCHE BIOTECHNOLOGIES, INC.

Addresses

100 CARDINAL WAY, REDWOOD CITY, CA 94063

1035 O-BRIEN DRIVE, SUITE A, MENLO PARK, CA 94025

1035 O-BRIEN DRIVE, MENLO PARK, CA 94025

665 THIRD STREET, SUITE 250, SAN FRANCISCO, CA 94107

Phone Numbers

(650) 656-9323
650-272-6269
650-735-1324

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$198,581,037.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-02-07 
$127,800,000.00 
$127,800,000.00 
$0.00 
Equity 
3
2014-08-05 
$9,999,995.00 
$9,999,995.00 
$0.00 
Equity 
2
2014-04-16 
$55,127,152.00 
$55,978,020.00 
$850,868.00 
Equity 
1
2010-09-07 
$5,653,890.00 
$6,138,277.00 
$484,387.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LINDA 
 
BAIN 
EXECUTIVE OFFICER
AVALANCHE BIOTECHNOLOGIES, INC.   |  AUTOLUS THERAPEUTICS PLC
MARK 
 
BLUMENKRANZ 
DIRECTOR
OPTIMEDICA CORP   |  OCULEVE, INC.   |  AVALANCHE BIOTECHNOLOGIES, INC.
MARK 
S. 
BLUMENKRANZ 
DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.   |  KALA PHARMACEUTICALS, INC.   |  KALA BIO, INC.
THOMAS 
 
CHALBERG 
EXECUTIVE OFFICER, DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.   |  ONCORUS, INC.
THOMAS 
W. 
CHALBERG 
EXECUTIVE OFFICER, DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.
LAURENT 
 
FISCHER 
EXECUTIVE OFFICER, DIRECTOR
TOBIRA THERAPEUTICS, INC.   |  LYCIA THERAPEUTICS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
MEHDI 
 
GASMI 
EXECUTIVE OFFICER
AVALANCHE BIOTECHNOLOGIES, INC.
SOO 
 
HONG 
DIRECTOR
ADVERUM BIOTECHNOLOGIES, INC.
HANS 
 
HULL 
EXECUTIVE OFFICER
AVALANCHE BIOTECHNOLOGIES, INC.
MARK 
 
LUPHER 
DIRECTOR
PROMEDIOR INC   |  ADVERUM BIOTECHNOLOGIES, INC.
PATRICK 
 
MACHADO 
DIRECTOR
TURNSTONE BIOLOGICS CORP.   |  CHIMERIX INC   |  ADVERUM BIOTECHNOLOGIES, INC.   |  ALUMIS INC.   |  AVENZO THERAPEUTICS, INC.
JOHN 
 
MCLAUGHLIN 
DIRECTOR
RAMIUS IDF LLC   |  RAMIUS IDF MASTER FUND LLC   |  AVALANCHE BIOTECHNOLOGIES, INC.   |  GALILEO EDUCATION, INC.   |  GALILEO EDUCATION HOLDINGS, LLC
C. DAVID 
 
NICHOLSON 
DIRECTOR
ADVERUM BIOTECHNOLOGIES, INC.
RABIA 
GURSES 
OZDEN 
DIRECTOR
ADVERUM BIOTECHNOLOGIES, INC.
LINDA 
 
RUBINSTEIN 
EXECUTIVE OFFICER
SENSOR INNOVATIONS INC   |  ADVERUM BIOTECHNOLOGIES, INC.
STEVEN 
 
SCHWARTZ 
DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.   |  UBBIGO INC   |  TORCHLIGHT DEBT OPPORTUNITY FUND V, LP   |  222 JACKSON STREET, LLC   |  1831 RIVERSIDE DRIVE, LLC   |  INFORMATION INTERNATIONAL ASSOCIATES HOLDINGS, LLC   |  VIE, INC.   |  HEKLA PARTNERS, LP   |  VA PRO 7 SNF OPERATIONS HOLDINGS LLC   |  H.I.G. REALTY CREDIT REIT, LLC   |  POSH GROUP INC.
STEVEN 
D. 
SCHWARTZ 
DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.
STEVEN 
D. 
SCHWARZ 
DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.
JAMES 
 
SCOPA 
DIRECTOR
TV2 HOLDING CO   |  ASTUTE MEDICAL, INC.   |  CONATUS PHARMACEUTICALS INC   |  TRIVASCULAR TECHNOLOGIES, INC.   |  IDUN PHARMACEUTICALS INC   |  BLADE THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
SETAREH 
 
SEYEDKAZEMI 
EXECUTIVE OFFICER
ADVERUM BIOTECHNOLOGIES, INC.
KISHOR 
PETER 
SOPARKAR 
EXECUTIVE OFFICER
ADVERUM BIOTECHNOLOGIES, INC.
DAWN 
 
SVORONOS 
DIRECTOR
PTC THERAPEUTICS, INC.   |  AGNOVOS BIOSCIENCE, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
REED 
 
TUCKSON 
DIRECTOR
INFORM GENOMICS, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
PAUL 
 
WACHTER 
DIRECTOR
AVALANCHE BIOTECHNOLOGIES, INC.   |  ATTN: INC.   |  MSA ACCELERATION PARTNERS, L.P.   |  MSA ACCELERATION PARTNERS B, L.P.
PAUL 
D. 
WACHTER 
DIRECTOR
CONTENT PARTNERS GP, LLC   |  AVALANCHE BIOTECHNOLOGIES, INC.
SCOTT 
 
WHITCUP 
DIRECTOR
MENLO THERAPEUTICS, INC.   |  ANIVIVE LIFESCIENCES, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-02-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-02-07 
2014-09-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-08-05 
2014-04-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-16 
2013-11-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY, LLC
7616
NONE
NONE
TRUIST SECURITIES, INC.
6271
NONE
NONE
COWEN AND COMPANY, LLC
NONE